niacinamide has been researched along with n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelling, SJ; Rippmann, JF; Sanderson, MP; Schnapp, A | 1 |
1 other study(ies) available for niacinamide and n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine
Article | Year |
---|---|
Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cells.
Topics: Animals; Anti-Allergic Agents; Basophils; Cell Line; Gene Expression Regulation, Enzymologic; Humans; Intracellular Signaling Peptides and Proteins; Mice; Niacinamide; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Receptors, IgE; RNA, Small Interfering; Signal Transduction; Syk Kinase; Tumor Necrosis Factor-alpha | 2010 |